Lataa...
RNF181 modulates Hippo signaling and triple negative breast cancer progression
BACKGROUND: Breast cancer ranks No. 1 in women cancer incidence, while triple negative breast cancer (TNBC) is the most aggressive and the worst prognostic subtype in all breast cancer subtypes. Compared with estrogen receptor alpha positive breast cancer, which could be well controlled by endocrine...
Tallennettuna:
| Julkaisussa: | Cancer Cell Int |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7339498/ https://ncbi.nlm.nih.gov/pubmed/32655323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-020-01397-3 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|